Amphenol vs Johnson & Johnson: Founders, CEOs and History
Amphenol was founded in 1932 by Arthur J. Schmitt and is led by R. Adam Norwitt. Johnson & Johnson was founded in 1886 by Robert Wood Johnson, James Wood Johnson, Edward Mead Johnson and is led by Joaquin Duato.
Company facts
Amphenol
- Founded
- 1932
- Headquarters
- Wallingford, Connecticut
- Current CEO
- R. Adam Norwitt
- Employees
- 170,000
Johnson & Johnson
- Founded
- 1886
- Headquarters
- New Brunswick, New Jersey
- Current CEO
- Joaquin Duato
- Employees
- 140,800
Founders
Amphenol
Arthur J. Schmitt
Amphenol was founded in Chicago in 1932 by an effective, pragmatic entrepreneur named Arthur J. Schmitt.
Johnson & Johnson
Robert Wood Johnson
Robert Wood Johnson (1845-1910) co-founded Johnson & Johnson in 1886 and served as its first president.
James Wood Johnson
James Wood Johnson (1856-1932) co-founded J&J with his brothers in 1886. An engineer by trade, he designed the early manufacturing machinery that allowed the company to mass-produce sterile surgical dressings.
Edward Mead Johnson
Edward Mead Johnson (1852-1934) co-founded J&J in 1886, bringing crucial sales and marketing expertise to the early business.
CEOs and their tenures
Amphenol
- Arthur J. Schmitt1932–1964
Founder and Chief Executive Officer
Arthur J. Schmitt founded American Phenolic Corporation in Chicago in 1932 and led it as chief executive until 1964.
Source - Martin H. Loeffler1996–2008
Former Chief Executive Officer and Chairman
Martin H. Loeffler was Amphenol's chief executive from 1996 to 2008, president from 1987 to 2006 and chairman of the board from 1997 until he retired from the board at the May 2026 annual meeting.
Source - R. Adam Norwitt2009–present
Chairman, President and Chief Executive Officer
R. Adam Norwitt has been Amphenol's chief executive since January 1, 2009 and added the role of chairman of the board in 2026. Net sales grew from $2.82 billion in 2009 to $23.09 billion in fiscal 2025 and the GAAP operating margin reached a record 25.4%.
Source
Johnson & Johnson
- Ralph Larsen1989–2002
Former Chairman and Chief Executive Officer
Larsen's acquisitions, including Neutrogena, Cordis, DePuy, and Centocor, broadened J&J into medical devices and biologics, laying groundwork for today's MedTech segment and immunology franchise.
Source - William Weldon2002–2012
Former Chairman and Chief Executive Officer
Weldon's later years were overshadowed by a wave of consumer product recalls, including Tylenol and Motrin, tied to manufacturing-quality problems.
Source - Alex Gorsky2012–2022
Former Chairman and Chief Executive Officer
Gorsky's tenure set up the 2023 Kenvue separation completed under his successor and saw J&J's single-dose COVID-19 vaccine authorized in 2021. He also oversaw the $30 billion Actelion acquisition in 2017 and the early years of talc litigation.
Source - Joaquin Duato2022–present
Chairman and Chief Executive Officer
Under Duato, J&J's sales reached $94.193 billion in FY2025 with $26.804 billion in net earnings, and the company guides to its first $100 billion year in 2026. He also launched the DePuy Synthes separation and the 2026 talc settlement proposal.
Source
Timeline: Amphenol and Johnson & Johnson side by side
1886Johnson & Johnson
Johnson & Johnson Founded
Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson found the company in New Brunswick, New Jersey, with 14 employees, to mass-produce sterile surgical dressings after Robert was inspired by antiseptic pioneer Joseph Lister's 1885 warnings about i…
1920Johnson & Johnson
Band-Aid Brand Adhesive Bandages Introduced
J&J introduces the first mass-produced adhesive bandage, sold under the Band-Aid brand starting in 1921; it becomes one of the most recognized consumer-health brands in the world before J&J later spins its consumer division out as Kenvue in 2023.
1932Amphenol
Arthur J. Schmitt founds American Phenolic Corporation
Arthur J. Schmitt incorporates American Phenolic Corporation in Chicago with a patented molded phenolic radio tube socket, establishing the company's foundation in electronic component manufacturing.
1936Amphenol
Introduction of industry-standard 75 series microphone connector and lock-in socket
Amphenol introduces the 75 series uniform microphone connector and a lock-in socket for radio tubes, both becoming industry standards and attracting RCA as a major customer ordering 10,000 sockets daily.
1942Amphenol
Primary supplier of AN connectors for WWII Allied forces
Amphenol becomes a critical defense supplier, with its 5015 AN circular connectors becoming standard equipment on military aircraft and communications gear; A-N connector shipments increase 13,572% from January 1941 to March 1943.
1942Amphenol
Official name change to Amphenol Electronics Corporation
The company officially changes its name from American Phenolic Corporation to Amphenol Electronics Corporation, formalizing the shorthand name customers had used for years.
1943Johnson & Johnson
Robert Wood Johnson II Writes 'Our Credo'
Chairman Robert Wood Johnson II authors 'Our Credo,' a one-page statement ranking the company's responsibilities to customers, employees, communities, and shareholders in that order; it remains J&J's official governing philosophy and was later cited as the bas…
1944Johnson & Johnson
J&J Goes Public
Johnson & Johnson lists publicly, becoming an independent, market-traded company as it expands into a diversified healthcare business under Chairman Robert Wood Johnson II.
1945Amphenol
Initial public offering
Amphenol raises $1.5 million from convertible debentures and sells 345,000 shares at $10 per share, giving the company a $4 million market capitalization and providing capital for post-war diversification.
1951Amphenol
Amphenol engineers develop the BNC connector
Amphenol engineers Paul Neill and Carl Concelman develop the bayonet coupled BNC coaxial connector, which becomes a standard interface in radio frequency and test equipment applications.
1957Amphenol
NYSE listing
Amphenol Electronics Corporation lists on the New York Stock Exchange, marking its transition to a major public industrial company.
1958Amphenol
Merger with George W. Borg Corporation
Amphenol completes its largest transaction to date, merging with the George W. Borg Corporation, a maker of automobile clocks, electronic instruments and deep pile fabrics, and is renamed Amphenol-Borg Electronics Corporation.
1967Amphenol
Acquisition by Bunker-Ramo Corporation
Bunker-Ramo Corporation acquires Amphenol, which begins operating as a subsidiary and passes through successive corporate owners for the next 24 years.
1981Amphenol
Allied Corporation buys Bunker-Ramo for $358 million
Allied Corporation acquires Bunker-Ramo for $358 million, including the Amphenol division, making Amphenol part of a larger industrial conglomerate.
1982Johnson & Johnson
Tylenol Cyanide Poisonings and Nationwide Recall
After seven people in the Chicago area die from cyanide-laced Extra-Strength Tylenol capsules, J&J issues a nationwide recall of 31 million bottles within a week -- far beyond what investigators said was necessary -- citing Our Credo's customer-safety priority…
1987Amphenol
LPL Investment leveraged buyout for $430 million
LPL Investment buys Amphenol from Allied in a leveraged buyout valued at $430 million in cash, and the decentralized management style that defines the modern company takes hold. Martin H. Loeffler becomes president in the same year.
1991Amphenol
Second IPO on NYSE under ticker APH
Amphenol returns to public markets with a second initial public offering on the New York Stock Exchange under ticker APH, beginning the modern era of sustained growth and shareholder returns.
2005Amphenol
Acquisition of Teradyne connector business for $390 million
Amphenol acquires Teradyne's connection systems business for $390 million in October 2005, expanding its presence in high speed data and backplane connectors for the growing IT datacom market.
2012Johnson & Johnson
Alex Gorsky Becomes CEO
Gorsky succeeds William Weldon as CEO amid a period of manufacturing-quality recalls, and spends the next decade restoring J&J's operational reputation while expanding the pharmaceutical and MedTech businesses and developing a single-dose COVID-19 vaccine duri…
2016Amphenol
Acquisition of FCI Asia for $1.275 billion
Amphenol acquires FCI Asia from affiliates of Bain Capital for $1.275 billion in January 2016, strengthening its global connector footprint and adding high speed backplane and board-to-board capability.
2021Amphenol
Acquisition of MTS Systems Corporation for $1.7 billion
Amphenol acquires MTS Systems for $1.7 billion in April 2021, adding advanced sensor capability that deepens its position in industrial and automotive sensing.
2022Johnson & Johnson
Joaquin Duato Becomes CEO
Duato becomes CEO in January 2022, later adding the chairman title, and begins preparing the separation of J&J's consumer-health business from its medicine and device operations.
2023Johnson & Johnson
Kenvue Separation
J&J completes the spinoff of its consumer-health business (Band-Aid, Tylenol, Listerine, Neutrogena) as the standalone public company Kenvue, narrowing J&J around its higher-margin Innovative Medicine and MedTech segments.
2024Amphenol
Acquisition of Carlisle Interconnect Technologies for about $2.0 billion
Amphenol completes the purchase of Carlisle Interconnect Technologies from Carlisle Companies in May 2024 for about $2.0 billion, expanding aerospace, defense and medical harsh environment interconnect capability.
2025Amphenol
Completion of the $2.1 billion CommScope outdoor wireless and DAS purchase
Amphenol completes the acquisition of CommScope's Outdoor Wireless Networks and Distributed Antenna Systems businesses, including Andrew, for $2.1 billion in cash. The businesses had about $1.2 billion of 2024 sales.
2025Amphenol
Record fiscal 2025 revenue of $23.09 billion, up 52%
Amphenol reports record full year 2025 net sales of $23.09 billion, up 52% year over year and 38% organically, with a 25.4% GAAP operating margin, $4.4 billion of free cash flow and Communications Solutions sales up 91% to about $12.1 billion.
2025Johnson & Johnson
FY2025 Sales of $94.193B
Johnson & Johnson reports $94.193 billion in sales and $26.804 billion in net earnings, split roughly 64% Innovative Medicine and 36% MedTech, both segments growing about 6% year over year.
2025Johnson & Johnson
Orthopaedics Separation Announced
In October 2025 J&J announced plans to separate its orthopaedics business as a standalone company operating as DePuy Synthes, targeting completion in 2027.
2026Amphenol
Completion of the $10.5 billion CommScope CCS acquisition
Amphenol closes its largest acquisition, buying CommScope's Connectivity and Cable Solutions business for $10.5 billion on January 12, 2026. Amphenol also acquired the CommScope name and expects the business to generate about $4.1 billion of sales in 2026.
2026Amphenol
Norwitt named chairman as Loeffler retires from the board
Amphenol announces on February 4, 2026 that chief executive R. Adam Norwitt will also become chairman of the board at the May 2026 annual meeting, as Martin H. Loeffler retires from the board after more than five decades with the company.
2026Johnson & Johnson
Proposed Talc Resolution and Raised Guidance
J&J raised 2026 sales guidance to about $101.1 billion after Q2 sales of $25.31 billion, and on July 27, 2026 proposed an estimated $5.5 billion resolution of remaining ovarian talc claims.
Acquisitions
Amphenol
- CommScope Connectivity and Cable Solutions (CCS)2026$10.5B
- CommScope Outdoor Wireless Networks and Distributed Antenna Systems businesses (Andrew)2025$2.1B
- Rochester Sensors2025Undisclosed
- Trexon2025$1B
- Carlisle Interconnect Technologies (CIT)2024$2B
Johnson & Johnson
- Intra-Cellular Therapies2025$14.6B
- Shockwave Medical2024$13.1B
- Kenvue separation2023Undisclosed
- Abiomed2022$16.6B
- Actelion2017$30B
Questions about Amphenol vs Johnson & Johnson
Who is the CEO of Amphenol Corporation and Johnson & Johnson?
Amphenol Corporation is led by R. Adam Norwitt and Johnson & Johnson is led by Joaquin Duato. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Amphenol Corporation founded vs Johnson & Johnson?
Johnson & Johnson was founded in 1886 — 46 years before Amphenol Corporation, which was founded in 1932. Johnson & Johnson's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Amphenol Corporation.
How many employees does Amphenol Corporation have compared to Johnson & Johnson?
Amphenol Corporation employs approximately 170,000 people, while Johnson & Johnson employs approximately 140,800. Amphenol Corporation has the larger workforce at 170,000 employees, compared to Johnson & Johnson's 140,800. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Amphenol Corporation and Johnson & Johnson headquartered?
Both Amphenol Corporation and Johnson & Johnson are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded Amphenol Corporation and Johnson & Johnson?
Amphenol Corporation was founded by Arthur J. Schmitt. Johnson & Johnson was founded by Robert Wood Johnson, James Wood Johnson, Edward Mead Johnson.
Which company has a longer operating history — Amphenol Corporation or Johnson & Johnson?
Johnson & Johnson has been operating for approximately 140 years, making it the more established of the two companies. Amphenol Corporation has been in operation for around 94 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Amphenol vs Johnson & Johnson overview